OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert BNTX.../  DE000ME5DL17  /

Stuttgart
5/17/2024  9:50:21 PM Chg.-1.07 Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
81.76EUR -1.29% -
Bid Size: -		 -
Ask Size: -		 BioNTech SE - USD 6/28/2024 Call
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 5/17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 5/9 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 5/6 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 5/6 Europe mixed premarket with data on the limelight
GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 4/4 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 3/28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 3/20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 3/20 Europe mixed premarket amid data
GlobeNewswire 3/14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 3/12 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 3/11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 3/11 FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...
GlobeNewswire 3/11 DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 3/11 BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline ...
GlobeNewswire 3/11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 3/11 BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Sub...